These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2862557)

  • 1. HLA antibodies detected by ELISA HTLV-III antibody kits.
    Hunter JB; Menitove JE
    Lancet; 1985 Aug; 2(8451):397. PubMed ID: 2862557
    [No Abstract]   [Full Text] [Related]  

  • 2. False-positive anti-HTLV-III assay results and HLA-DR4.
    Kenrick KG; Bolton W; Doran TJ
    Med J Aust; 1985 Jul; 143(2):88-9. PubMed ID: 2991712
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.
    Kühnl P; Seidl S; Holzberger G
    Lancet; 1985 May; 1(8439):1222-3. PubMed ID: 2860429
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-DR antibodies and HTLV-III antibody ELISA testing.
    Weiss SH; Mann DL; Murray C; Popovic M
    Lancet; 1985 Jul; 2(8447):157. PubMed ID: 2862348
    [No Abstract]   [Full Text] [Related]  

  • 5. [False-positive results in the detection of anti-LAV/HTLV-III antibodies by enzyme immunoassay].
    Näher H; Tilgen W; Tilz G; Petzoldt D
    Hautarzt; 1986 Jun; 37(6):338-40. PubMed ID: 3013804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
    Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
    J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of eight ELISA kits for the detection of anti-LAV/HTLV-III antibodies.
    Courouce AM
    Lancet; 1986 May; 1(8490):1152-3. PubMed ID: 2871401
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies reactive with non-polymorphic epitopes on HLA molecules cause false-positive HIV antibody tests on African samples of serum.
    Aceti A; Terzaroli P; Paparo BS; Celestino D; Sebastiani A; Bile K; Tanigaki N; Tosi R; Ameglio F
    J Infect; 1990 Jan; 20(1):84-6. PubMed ID: 1688903
    [No Abstract]   [Full Text] [Related]  

  • 9. LAV/HTLV-III antibodies in patients treated with intravenous gammaglobulins.
    Kanoh T; Ohno T; Funakoshi N; Fujii H; Okada T
    Tohoku J Exp Med; 1986 Nov; 150(3):361-2. PubMed ID: 2435020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrandom association of cellular antigens with HTLV-III virions.
    Hoxie JA; Fitzharris TP; Youngbar PR; Matthews DM; Rackowski JL; Radka SF
    Hum Immunol; 1987 Jan; 18(1):39-52. PubMed ID: 3542913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of HTLV III screening tests in Christchurch.
    Field D; Whyte G; Robertson S
    N Z Med J; 1985 Nov; 98(791):992-3. PubMed ID: 3001606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies reactive with nonpolymorphic epitopes on HLA molecules interfere in screening tests for the human immunodeficiency virus.
    Ameglio F; Dolei A; Benedetto A; Sorrentino R; Tanigaki N; Tosi R
    J Infect Dis; 1987 Dec; 156(6):1034-5. PubMed ID: 2445831
    [No Abstract]   [Full Text] [Related]  

  • 14. The association of HLA and immune responses to bovine collagen implants.
    Vanderveen EE; McCoy JP; Schade W; Kapur JJ; Hamilton T; Ragsdale C; Grekin RC; Swanson NA
    Arch Dermatol; 1986 Jun; 122(6):650-4. PubMed ID: 2424374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
    Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
    J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False Positive Class II HLA Antibody Reaction Due to Antibodies Against Denatured HLA Might Differ Between Assays: One Lambda vs. Immucor.
    Park BG; Park Y; Kim BS; Kim YS; Kim HS
    Ann Lab Med; 2020 Sep; 40(5):424-427. PubMed ID: 32311858
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for HTLV-III antibody.
    Handsfield HH
    N Engl J Med; 1985 Oct; 313(14):888. PubMed ID: 3861938
    [No Abstract]   [Full Text] [Related]  

  • 19. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA system in rheumatoid arthritis.
    Panayi GS
    Eur J Rheumatol Inflamm; 1982; 5(4):423-4. PubMed ID: 6983961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.